James Patrick Kelly Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Patrick Kelly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Patrick Kelly. James Patrick Kelly is a EVP & Chief Financial Officer in Vanda Pharmaceuticals Inc. ($VNDA) and a SVP, CFO & Treasurer in Vanda Pharmaceuticals Inc. ($VNDA) and a SVP, CFO, Sec & Treasurer in Vanda Pharmaceuticals Inc. ($VNDA) and an Executive Vice-President & CFO in SUPERNUS PHARMACEUTICALS, INC. ($SUPN).
Address: 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE 20850 MD
Companies in which James Patrick Kelly is an Insider
SUPERNUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James Patrick Kelly: Executive Vice-President & CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2021
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vanda Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James Patrick Kelly: EVP & Chief Financial Officer, SVP, CFO & Treasurer, SVP, CFO, Sec & Treasurer
Holdings: 192,758 shares
Current Value: $2,631,147
Latest Transaction: Mar 04 2020
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James Patrick Kelly
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Kelly James Patrick | Executive Vice-Pres ... | Option Exercise | A | 29.61 | 15,000 | 444,150 | 15,000 | |
| Mar 04 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 10.76 | 5,889 | 63,359 | 186,869 | 192.8 K to 186.9 K (-3.06 %) |
| Mar 04 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 10.19 | 12,968 | 132,087 | 192,758 | 205.7 K to 192.8 K (-6.30 %) |
| Jan 06 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 15.94 | 4,020 | 64,086 | 205,726 | 209.7 K to 205.7 K (-1.92 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 19.88 | 8,751 | 173,961 | 209,746 | 218.5 K to 209.7 K (-4.01 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 20.15 | 4,976 | 100,271 | 218,497 | 223.5 K to 218.5 K (-2.23 %) |
| Mar 01 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Option Exercise | A | 20.62 | 70,000 | 1,443,400 | 70,000 |